Brief: China Shineway Pharmaceutical Says HY Profit And Total Comprehensive Income Rmb331.1 Mln
30/08/2022 06:51
Aug 30 (Reuters) - China Shineway Pharmaceutical Group Ltd
2877.HK :
* HY PROFIT AND TOTAL COMPREHENSIVE INCOME RMB331.1 MILLION
VERSUS
RMB308.5 MILLION
* HY REVENUE RMB1.82 BILLION VERSUS RMB1.55 BILLION
* DECLARED SECOND INTERIM DIVIDEND OF RMB11 CENTS PER SHARE
Further company coverage: 2877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln